HERNANDEZ JOSEPH (Chief Executive Officer) reported 2 transactions at CLARUS THERAPEUTICS HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/27/2022ACC: 0001213900-22-021910
DirectorOfficer10% Owner· Chief Executive Officer
Since Dec 2020
+4.62M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
4.68M acquired · 65K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−65K
Price / share
—
Trade value
—
% of position
5.0%
4/25/2022
1.30M→1.24M
Common Stock
Direct
Shares
+1.24M
Price / share
—
Trade value
—
% of position
32193.0%
4/25/2022
3.84K→1.24M
Total
Net shares
+1.17M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/25/2022 | J · J | −65K | — | — | 5.0% | 1.30M | 1.24M |
| Common Stock Direct | 4/25/2022 | J · J | +1.24M | — | — | 32193.0% | 3.84K | 1.24M |
| Total | +1.17M | $0.00 | ||||||
Derivative Transactions1
Warrants
Direct
Converts to
Common Stock
3.44M shares
Shares
+3.44M
Strike price
11.5
Held after
3.44M
Exercisable
—
4/25/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants Direct | Common Stock3.44M shares | 4/25/2022 | A · Award | +3.44M | 11.5 | — | 3.44M |